# Combined Lactobacilli (Reuteri LMG P-27481 and GG ATCC 53103) to Prevent Antibiotic Associated Symptoms in Children

> **NCT04836013** · NA · UNKNOWN · sponsor: **Università degli Studi dell'Insubria** · enrollment: 216 (estimated)

## Conditions studied

- Diarrhea Caused by Drug
- Abdominal Pain

## Interventions

- **DIETARY_SUPPLEMENT:** combined Lactobacilli
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04836013
- **Lead sponsor:** Università degli Studi dell'Insubria
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-13
- **Primary completion:** 2021-11-30
- **Final completion:** 2022-04-13
- **Target enrollment:** 216 (ESTIMATED)
- **Last updated:** 2021-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04836013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04836013, "Combined Lactobacilli (Reuteri LMG P-27481 and GG ATCC 53103) to Prevent Antibiotic Associated Symptoms in Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04836013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*